Stéphanie L. Gaillard, MD, PhD

Assistant Professor of Medicine
Department / Division:
Medicine / Medicine - Oncology
DUMC 3079
Durham, NC 27710
Appointment Telephone:
Office Telephone:
  • MD, Duke University School of Medicine, 2006
  • PhD, Duke University School of Medicine, 2005
  • Internal Medicine, Johns Hopkins School of Medicine (Maryland), 2006-2009
  • Clinical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine (Maryland), 2009-2012
Clinical Interests:
Gynecologic malignancies including advanced ovarian, cervical and endometrial cancers; chemotherapy and biologic therapies including immunotherapy; cancer clinical trials
Research Interests:
Dr. Stéphanie Gaillard is an Assistant Professor in Medical Oncology at the Duke Cancer Institute. Dr. Gaillard is board certified by the American Board of Internal Medicine in both Internal Medicine and Medical Oncology. At Duke, she focuses on treating patients with gynecologic malignancies and conducts basic science and clinical research. Dr. Gaillard’s laboratory research focuses on elucidating the biology of ovarian cancer, especially metabolic changes in the development of ovarian tumors, and mechanisms of resistance to chemotherapy. Her clinical research interests center on the development of novel therapeutic strategies for the treatment of ovarian cancer through early phase clinical trials. In addition to the Ovarian Cancer Research Fund Liz Tilberis Grant, Dr. Gaillard has received a Department of Defense Breast Cancer Research Program pre-doctoral research award and a Conquer Cancer Foundation Young Investigator Award.
Representative Publications:
  • Grasfeder, LL; Gaillard, S; Hammes, SR; Ilkayeva, O; Newgard, CB; Hochberg, RB; Dwyer, MA; Chang, CY; McDonnell, DP. Fasting-induced hepatic production of DHEA is regulated by PGC-1alpha, ERRalpha, and HNF4alpha. Molecular endocrinology (Baltimore, Md.). 2009;23:1171-1182.  Abstract
  • Stein, RA; Gaillard, S; McDonnell, DP. Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 2009;114:106-112.  Abstract
  • Gaillard, S; Dwyer, MA; McDonnell, DP. Definition of the molecular basis for estrogen receptor-related receptor-alpha-cofactor interactions. Molecular endocrinology (Baltimore, Md.). 2007;21:62-76.  Abstract
  • Gaillard, S; Grasfeder, LL; Haeffele, CL; Lobenhofer, EK; Chu, TM; Wolfinger, R; Kazmin, D; Koves, TR; Muoio, DM; Chang, CY; McDonnell, DP. Receptor-selective coactivators as tools to define the biology of specific receptor-coactivator pairs. Molecular Cell. 2006;24:797-803.  Abstract
end fo content area